Systems Biology of Cognitive Decline in Older Adults with HIV Infection

HIV 感染老年人认知能力下降的系统生物学

• 批准号: 9105762
• 负责人: Dana H. Gabuzda
• 金额: $ 52.27万
• 依托单位: DANA-FARBER CANCER INST
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-08-01 至 2019-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9105762
• 关键词: Affect; Age; Aging; Automobile Driving; Autophagocytosis; Biochemical Pathway; Bioinformatics; Biological; Biological Models; Biology; Blood Vessels; Bone Diseases; Brain Pathology; Cardiovascular system; Cell physiology; Cholestasis; Chronic; Classification; Clinical; Cognition Disorders; Cohort Studies; Computer Simulation; Computer software; Control Groups; Data; Data Analyses; Data Set; Development; Disease; Elderly; Fatty Liver; Functional disorder; Genes; Goals; HDL-triglyceride; HIV; HIV Infections; HIV Seropositivity; HIV-associated neurocognitive disorder; HIV/HCV; Hepatic; Hepatitis; Hepatitis C; Hepatotoxicity; Impaired cognition; Incidence; Inflammation; Inflammatory Response; Interferons; Kidney Diseases; LDL Cholesterol Lipoproteins; Link; Lipids; Liquid substance; Liver; Liver diseases; Metabolic; Metabolic Pathway; Methods; Mitochondria; Modeling; Motor; Outcome; Pathway Analysis; Pathway interactions; Patients; Pattern; Pharmaceutical Preparations; Plasma; Play; Population; Process; Role; Sampling; Systems Biology; Testing; Tissue Sample; Tissues; Toxic effect; Virus Replication; White Matter Disease; age related; antiretroviral therapy; base; biological adaptation to stress; disorder risk; executive function; insight; lipid metabolism; longitudinal analysis; metabolome; metabolomics; mitochondrial dysfunction; model building; nervous system disorder; neurobehavioral disorder; neurocognitive disorder; neurocognitive test; novel therapeutics; success; transcriptome; transcriptomics; white matter

DESCRIPTION (provided by applicant): The goal of this project is to understand the role of dysregulated lipid metabolism in development of HIV-associated neurocognitive disorders (HAND) in older HIV patients on long-term antiretroviral therapy (ART), and how these processes are influenced by hepatic dysfunction, chronic inflammation, and aging. Long-term ART is associated with metabolic abnormalities and increased risk of diseases typically associated with aging including cardiovascular, liver, kidney, bone, and neurological disorders. Mild forms of HAND affect 30-50% of HIV patients on long-term ART, and are more frequent in HIV patients over age 50. In preliminary studies, we performed untargeted metabolite profiling and identified 126 metabolites altered in plasma of HIV patients on suppressive ART, of which 47% were lipids. Lipid alterations correlated with markers of hepatic and mitochondrial dysfunction, and represented specific classes distinct from traditional markers. Some altered lipids belonging to specific classes correlated with cognitive impairment, while others correlated primarily with deficits in motor or executive function, based on analyses using normalized neurocognitive test scores (T scores). We hypothesize that dysregulated lipid metabolism, a consequence of hepatic dysfunction induced by HIV or HIV/HCV infection, chronic inflammation, hepatotoxicity of some ART drugs, and other factors, promotes white matter abnormalities and cognitive decline in older adults with HIV infection. Aging modifies these processes through age-related alterations in lipid metabolism, mitochondrial function, autophagy, and inflammatory responses. To investigate this hypothesis, we will use systems biology approaches to analyze large-scale clinical, biological, metabolomics, and transcriptomics datasets from HIV patients age 50 and older on long-term ART with different clinical outcomes. Integrative data analysis and targeted experimentation will be used to computationally build models of relevant networks and pathways. These studies will create a new conceptual framework for understanding metabolic pathways driving HAND in older adults on long-term ART, which may provide important insights into the biology of cognitive and neurobehavioral disorders in other aging populations and developing new therapies.

描述（由申请人提供）：本项目的目标是了解脂质代谢失调在接受长期抗逆转录病毒治疗（ART）的老年HIV患者发生HIV相关神经认知障碍（HAND）中的作用，以及这些过程如何受到肝功能障碍、慢性炎症和衰老的影响。长期ART与代谢异常和通常与衰老相关的疾病（包括心血管、肝脏、肾脏、骨骼和神经系统疾病）风险增加有关。轻度HAND影响30-50%的长期抗逆转录病毒治疗的艾滋病毒患者，在50岁以上的艾滋病毒患者中更为常见。在初步研究中，我们进行了非靶向代谢物分析，并确定了126种代谢物在接受抑制性ART的HIV患者血浆中发生了变化，其中47%是脂质。脂质改变与肝脏和线粒体功能障碍的标志物相关，代表不同于传统标志物的特定类别。根据使用标准化神经认知测试分数（T分数）的分析，属于特定类别的一些改变的脂质与认知障碍相关，而其他改变的脂质主要与运动或执行功能的缺陷相关。我们假设，脂质代谢失调，由HIV或HIV/HCV感染、慢性炎症、某些ART药物的肝毒性和其他因素引起的肝功能障碍的结果，促进了HIV感染的老年人的白色异常和认知能力下降。衰老通过与年龄相关的脂质代谢、线粒体功能、自噬和炎症反应的改变来改变这些过程。为了研究这一假设，我们将使用系统生物学方法来分析50岁及以上长期接受ART治疗的HIV患者的大规模临床、生物学、代谢组学和转录组学数据集，这些患者具有不同的临床结局。综合数据分析和有针对性的实验将用于计算相关网络和途径的模型。这些研究将为理解长期接受ART的老年人中驱动HAND的代谢途径创建一个新的概念框架，这可能为其他老龄化人群中认知和神经行为障碍的生物学以及开发新疗法提供重要见解。